ATR icon

AptarGroup

148.05 USD
+2.03
1.39%
At close Apr 23, 4:00 PM EDT
After hours
148.05
+0.00
0.00%
1 day
1.39%
5 days
2.77%
1 month
0.04%
3 months
-7.25%
6 months
-11.69%
Year to date
-3.96%
1 year
5.64%
5 years
40.97%
10 years
135.22%
 

About: Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (49% of sales) and the United States (32%), Aptar aims to increase its presence in Asia (11%) and Latin America (8%). It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.

Employees: 13,500

0
Funds holding %
of 7,419 funds
0
Analysts bullish %
of 3 analysts

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

117% more first-time investments, than exits

New positions opened: 76 | Existing positions closed: 35

18% more repeat investments, than reductions

Existing positions increased: 177 | Existing positions reduced: 150

13% more capital invested

Capital invested by funds: $9.55B [Q3] → $10.8B (+$1.23B) [Q4]

7% more funds holding

Funds holding: 464 [Q3] → 495 (+31) [Q4]

1.9% more ownership

Funds ownership: 89.81% [Q3] → 91.71% (+1.9%) [Q4]

17% less funds holding in top 10

Funds holding in top 10: 6 [Q3] → 5 (-1) [Q4]

42% less call options, than puts

Call options by funds: $799K | Put options by funds: $1.37M

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$160
8%
upside
Avg. target
$168
14%
upside
High target
$175
18%
upside

3 analyst ratings

positive
100%
neutral
0%
negative
0%
Raymond James
Matt Roberts
0% 1-year accuracy
0 / 13 met price target
18%upside
$175
Outperform
Maintained
22 Apr 2025
Wells Fargo
Gabe Hajde
39% 1-year accuracy
25 / 64 met price target
15%upside
$170
Overweight
Maintained
10 Feb 2025
Baird
Ghansham Panjabi
11% 1-year accuracy
3 / 27 met price target
8%upside
$160
Outperform
Maintained
10 Feb 2025

Financial journalist opinion

Based on 3 articles about ATR published over the past 30 days

Neutral
Business Wire
6 days ago
Aptar Declares Quarterly Dividend
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Declares Quarterly Dividend.
Aptar Declares Quarterly Dividend
Neutral
Business Wire
1 week ago
Aptar Receives Platinum Rating from EcoVadis for the Fifth Consecutive Year
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Receives Platinum Rating from EcoVadis for the Fifth Consecutive Year.
Aptar Receives Platinum Rating from EcoVadis for the Fifth Consecutive Year
Neutral
Seeking Alpha
1 week ago
AptarGroup: Strong Pharma And Closure Growth To Offset Beauty Headwinds
AptarGroup is poised for growth in its Pharma and Closure segments, but challenges are expected in the Beauty segment. The prescription drug business is expected to drive revenue growth in the Pharma segment. Margin expansion anticipated from operational leverage, cost management, and premium product mix.
AptarGroup: Strong Pharma And Closure Growth To Offset Beauty Headwinds
Neutral
Business Wire
1 month ago
Aptar Recognized with Prestigious 'A' Score on the CDP Climate Change Assessment
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Recognized with Prestigious ‘A' Score on the CDP Climate Change Assessment.
Aptar Recognized with Prestigious 'A' Score on the CDP Climate Change Assessment
Neutral
Zacks Investment Research
2 months ago
Zacks Industry Outlook Packaging Corporation of America, Amcor, AptarGroup and Sonoco Products
Packaging Corporation of America, Amcor, AptarGroup and Sonoco Products have been highlighted in this Industry Outlook article.
Zacks Industry Outlook Packaging Corporation of America, Amcor, AptarGroup and Sonoco Products
Positive
Zacks Investment Research
2 months ago
AptarGroup Earnings Surpass Estimates in Q4, Increase 27% Y/Y
ATR's Q4 top line gains from improved performances of the Pharma and Closures segments.
AptarGroup Earnings Surpass Estimates in Q4, Increase 27% Y/Y
Neutral
Zacks Investment Research
2 months ago
International Markets and AptarGroup (ATR): A Deep Dive for Investors
Explore AptarGroup's (ATR) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
International Markets and AptarGroup (ATR): A Deep Dive for Investors
Neutral
Seeking Alpha
2 months ago
AptarGroup, Inc. (ATR) Q4 2024 Earnings Call Transcript
AptarGroup, Inc. (NYSE:ATR ) Q4 2024 Earnings Conference Call February 7, 2025 9:00 AM ET Company Participants Mary Skafidas - Senior Vice President, Investor Relations & Communications Stephan Tanda - President & Chief Executive Officer Vanessa Kanu - Executive Vice President & Chief Financial Officer Conference Call Participants George Staphos - Bank of America Ghansham Panjabi - Baird Matt Roberts - Raymond James Daniel Rizzo - Jefferies Matt Larew - William Blair Gabe Hajde - Wells Fargo Operator Ladies and gentlemen, thank you for standing by. Welcome to Aptar's 2024 Fourth Quarter and Annual Results Conference Call.
AptarGroup, Inc. (ATR) Q4 2024 Earnings Call Transcript
Positive
Zacks Investment Research
2 months ago
AptarGroup (ATR) Tops Q4 Earnings Estimates
AptarGroup (ATR) came out with quarterly earnings of $1.52 per share, beating the Zacks Consensus Estimate of $1.26 per share. This compares to earnings of $1.21 per share a year ago.
AptarGroup (ATR) Tops Q4 Earnings Estimates
Neutral
Business Wire
2 months ago
Aptar Reports Fourth Quarter and Annual 2024 Results
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Reports Fourth Quarter and Annual 2024 Results.
Aptar Reports Fourth Quarter and Annual 2024 Results
Charts implemented using Lightweight Charts™